Enzon Pharmaceuticals, Inc. (NASDAQ:ENZN)

CAPS Rating: 3 out of 5

A biopharmaceutical company dedicated to the development and commercialization of therapeutics to treat patients with cancer and adjacent diseases.

Recs

0
Player Avatar jsgant13 (97.73) Submitted: 9/13/2010 1:01:00 PM : Outperform Start Price: $10.95 ENZN Score: -59.89

baupost, deej and value

Report this Post Reply

Featured Broker Partners


Advertisement